These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 35897769)

  • 21. Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function.
    Golan R; Scovell JM; Ramasamy R
    Aging Male; 2015; 18(3):201-4. PubMed ID: 26075536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of leptin in neuroendocrine regulation of male reproduction.
    Landry D; Cloutier F; Martin LJ
    Reprod Biol; 2013 Mar; 13(1):1-14. PubMed ID: 23522066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone replacement therapy in obese males.
    Drewa T; Olszewska-Słonina D; Chlosta P
    Acta Pol Pharm; 2011; 68(5):623-7. PubMed ID: 21928705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible Role of GnIH as a Novel Link between Hyperphagia-Induced Obesity-Related Metabolic Derangements and Hypogonadism in Male Mice.
    Luo R; Chen L; Song X; Zhang X; Xu W; Han D; Zuo J; Hu W; Shi Y; Cao Y; Ma R; Liu C; Xu C; Li Z; Li X
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.
    Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S; Mohanty P
    Curr Mol Med; 2008 Dec; 8(8):816-28. PubMed ID: 19075678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive endocrine considerations and hormonal therapy for men with epilepsy.
    Herzog AG
    Epilepsia; 1991; 32 Suppl 6():S34-7. PubMed ID: 1959510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testicular volume and clinical correlates of hypothalamic-pituitary-testicular function: A cross-sectional study in obese men.
    Tang Fui MN; Hoermann R; Wittert G; Grossmann M
    Asian J Androl; 2020; 22(4):354-359. PubMed ID: 31535628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection.
    Cohen PG
    Med Hypotheses; 2001 Jun; 56(6):702-8. PubMed ID: 11399122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Testosterone replacement treatment in older people with and without co-morbidities].
    Zitzmann M
    Internist (Berl); 2020 Jun; 61(6):549-557. PubMed ID: 32377774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caloric restriction increases serum testosterone concentrations in obese male subjects by two distinct mechanisms.
    Schulte DM; Hahn M; Oberhäuser F; Malchau G; Schubert M; Heppner C; Müller N; Güdelhöfer H; Faust M; Krone W; Laudes M
    Horm Metab Res; 2014 Apr; 46(4):283-6. PubMed ID: 24198220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 20 years of leptin: role of leptin in human reproductive disorders.
    Chou SH; Mantzoros C
    J Endocrinol; 2014 Oct; 223(1):T49-62. PubMed ID: 25056118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy.
    Yeap BB; Grossmann M; McLachlan RI; Handelsman DJ; Wittert GA; Conway AJ; Stuckey BG; Lording DW; Allan CA; Zajac JD; Burger HG
    Med J Aust; 2016 Aug; 205(4):173-8. PubMed ID: 27510348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease.
    Romejko K; Rymarz A; Sadownik H; Niemczyk S
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.
    Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Sandhu S; Green K; Makdissi A; Hejna J; Chaudhuri A; Punyanitya M; Dandona P
    Diabetes Care; 2016 Jan; 39(1):82-91. PubMed ID: 26622051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the Hypothalamic-Pituitary-Testicular Axis: Pathophysiology of Hypogonadism.
    Sharma A; Jayasena CN; Dhillo WS
    Endocrinol Metab Clin North Am; 2022 Mar; 51(1):29-45. PubMed ID: 35216719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Still too early for androgen therapy of abdominal obesity in males--inspite of good results].
    Björntorp P; Mårin P; Holmäng S
    Lakartidningen; 1992 Apr; 89(18):1568-9. PubMed ID: 1579023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.